EI
INBX icon

Ethic Inc’s Inhibrx INBX Stock Holding History

Ethic Inc’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885K Sell
9,345
-143
-2% -$14.3K 0.01% 744
2026
Q1 		$638K Sell
9,488
-3,483
-27% -$258K 0.01% 785
2025
Q4 		$1.02M Sell
12,971
-1,516
-10% -$103K 0.02% 639
2025
Q3 		$488K Sell
14,487
-1,252
-8% -$30.8K 0.01% 844
2025
Q2 		$227K Buy
+15,739
New +$203K ﹤0.01% 1071

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ethic Inc's INBX Position: Q2 2026 in Review

Ethic Inc reduced its Inhibrx (INBX) stake by 1.5% in Q2 2026, selling an estimated $14.3K and leaving 9,345 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #744.

Ethic Inc first reported a position in INBX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.02M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Ethic Inc held 9,345 shares of Inhibrx worth $885K as of Q2 2026.
  • Ethic Inc sold 143 Inhibrx shares in Q2 2026, an estimated $14.3K.
  • Inhibrx made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #744 holding.
  • Ethic Inc first reported a position in Inhibrx in Q2 2025 and has held it in 5 quarters since.
  • Ethic Inc's Inhibrx position peaked at $1.02M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.